MiR-526b-3p Inhibits the Resistance of Glioma Cells to Adriamycin by Targeting MAPRE1

BACKGROUND: Cell resistance is the main reason for the high mortality in glioma. Adriamycin (ADR) is a treatment drug for glioma and often leads to chemoresistance. Previous studies have confirmed that the abnormal expression of microRNA (miRNA) affects the resistance of glioma cells. METHODS: RT-qP...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Lei, Xing, Shuyuan, Lang, Fuxin, Bao, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860534/
https://www.ncbi.nlm.nih.gov/pubmed/35198024
http://dx.doi.org/10.1155/2022/2402212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860534/
https://www.ncbi.nlm.nih.gov/pubmed/35198024
http://dx.doi.org/10.1155/2022/2402212

Ejemplares similares